Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 60

1.

Efficacy and safety of nortriptyline in functional dyspepsia in Asians: A randomized double-blind placebo-controlled trial.

Kaosombatwattana U, Pongprasobchai S, Limsrivilai J, Maneerattanaporn M, Leelakusolvong S, Tanwandee T.

J Gastroenterol Hepatol. 2018 Feb;33(2):411-417. doi: 10.1111/jgh.13914.

PMID:
28768370
2.

Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial.

Hudson B, Williman JA, Stamp LK, Alchin JS, Hooper GJ, Mangin D, Thompson BF, Toop L.

Trials. 2015 Oct 9;16:448. doi: 10.1186/s13063-015-0961-1.

3.

Effect of nortriptyline on symptoms of idiopathic gastroparesis: the NORIG randomized clinical trial.

Parkman HP, Van Natta ML, Abell TL, McCallum RW, Sarosiek I, Nguyen L, Snape WJ, Koch KL, Hasler WL, Farrugia G, Lee L, Unalp-Arida A, Tonascia J, Hamilton F, Pasricha PJ.

JAMA. 2013 Dec 25;310(24):2640-9. doi: 10.1001/jama.2013.282833.

4.

Effect of nortriptyline on brain responses to painful esophageal acid infusion in patients with non-erosive reflux disease.

Forcelini CM, Tomiozzo JC Jr, Farré R, Van Oudenhove L, Callegari-Jacques SM, Ribeiro M, Madalosso BH, Fornari F.

Neurogastroenterol Motil. 2014 Feb;26(2):187-95. doi: 10.1111/nmo.12251. Epub 2013 Nov 4.

PMID:
24188252
5.

Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled clinical trial.

Ghanizadeh A, Haghighat R.

Pediatr Nephrol. 2012 Nov;27(11):2091-2097. doi: 10.1007/s00467-012-2211-z. Epub 2012 Jun 15.

PMID:
22700161
6.

Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders.

Krymchantowski AV, da Cunha Jevoux C, Bigal ME.

J Headache Pain. 2012 Jan;13(1):53-9. doi: 10.1007/s10194-011-0395-4. Epub 2011 Oct 19.

7.

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ.

Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21.

PMID:
21658141
8.

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial.

Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M.

BMJ. 2008 May 31;336(7655):1223-7. doi: 10.1136/bmj.39545.852616.BE. Epub 2008 Apr 27.

9.

Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline.

Hall SM, Gorecki JA, Reus VI, Humfleet GL, Muñoz RF.

Nicotine Tob Res. 2007 Apr;9(4):467-71.

PMID:
17454701
10.

Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.

Khoromi S, Cui L, Nackers L, Max MB.

Pain. 2007 Jul;130(1-2):66-75. Epub 2006 Dec 19.

11.

A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results.

Haggsträm FM, Chatkin JM, Sussenbach-Vaz E, Cesari DH, Fam CF, Fritscher CC.

Pulm Pharmacol Ther. 2006;19(3):205-9. Epub 2006 Mar 6.

PMID:
16517193
12.

Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease.

Wagena EJ, Knipschild PG, Huibers MJ, Wouters EF, van Schayck CP.

Arch Intern Med. 2005 Oct 24;165(19):2286-92.

PMID:
16246996
13.

Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation.

Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R.

J Behav Health Serv Res. 2005 Oct-Dec;32(4):381-92.

PMID:
16215448
14.

A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.

Prochazka AV, Kick S, Steinbrunn C, Miyoshi T, Fryer GE.

Arch Intern Med. 2004 Nov 8;164(20):2229-33.

PMID:
15534159
15.

Extended nortriptyline and psychological treatment for cigarette smoking.

Hall SM, Humfleet GL, Reus VI, Muñoz RF, Cullen J.

Am J Psychiatry. 2004 Nov;161(11):2100-7.

PMID:
15514412
16.

Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.

Kimura M, Tateno A, Robinson RG.

Am J Geriatr Psychiatry. 2003 May-Jun;11(3):320-7.

PMID:
12724111
17.

Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants.

Nierenberg AA, Papakostas GI, Petersen T, Montoya HD, Worthington JJ, Tedlow J, Alpert JE, Fava M.

J Clin Psychopharmacol. 2003 Feb;23(1):92-5.

PMID:
12544380
18.

Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo.

da Costa CL, Younes RN, Lourenço MT.

Chest. 2002 Aug;122(2):403-8.

PMID:
12171809
19.

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.

Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Rowland KM Jr, Stella PJ, Johnson JA.

Pain. 2002 Jul;98(1-2):195-203.

PMID:
12098632
20.
21.

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 2001 Aug;62(8):597-604.

PMID:
11561930
22.

Sex-related differences in nortriptyline-induced side-effects among depressed patients.

Pomara N, Shao B, Choi SJ, Tun H, Suckow RF.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jul;25(5):1035-48.

PMID:
11444676
23.

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder.

Prince JB, Wilens TE, Biederman J, Spencer TJ, Millstein R, Polisner DA, Bostic JQ.

J Child Adolesc Psychopharmacol. 2000 Fall;10(3):193-204.

PMID:
11052409
24.

Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.

Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE.

Am J Psychiatry. 2000 Mar;157(3):351-9.

PMID:
10698809
25.

Accelerating antidepressant response in geriatric depression: a post hoc comparison of combined sleep deprivation and paroxetine versus monotherapy with paroxetine, nortriptyline, or placebo.

Green TD, Reynolds CF 3rd, Mulsant BH, Pollock BG, Miller MD, Houck PR, Mazumdar S, Dew MA, Kupfer DJ.

J Geriatr Psychiatry Neurol. 1999 Summer;12(2):67-71.

PMID:
10483927
26.

Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease.

Nelson JC, Kennedy JS, Pollock BG, Laghrissi-Thode F, Narayan M, Nobler MS, Robin DW, Gergel I, McCafferty J, Roose S.

Am J Psychiatry. 1999 Jul;156(7):1024-8.

PMID:
10401446
27.

Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy.

Reynolds CF 3rd, Miller MD, Pasternak RE, Frank E, Perel JM, Cornes C, Houck PR, Mazumdar S, Dew MA, Kupfer DJ.

Am J Psychiatry. 1999 Feb;156(2):202-8.

PMID:
9989555
28.

EEG sleep measures in later-life bereavement depression. A randomized, double-blind, placebo-controlled evaluation of nortriptyline.

Taylor MP, Reynolds CF 3rd, Frank E, Dew MA, Mazumdar S, Houck PR, Kupfer DJ.

Am J Geriatr Psychiatry. 1999 Winter;7(1):41-7.

PMID:
9919319
29.

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

Reynolds CF 3rd, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, Mazumdar S, Houck PR, Dew MA, Stack JA, Pollock BG, Kupfer DJ.

JAMA. 1999 Jan 6;281(1):39-45.

PMID:
9892449
30.

Combination of clomipramine and nortriptyline in the treatment of obsessive-compulsive disorder: a double-blind, placebo-controlled trial.

Noorbala AA, Hosseini SH, Mohammadi MR, Akhondzadeh S.

J Clin Pharm Ther. 1998 Apr;23(2):155-9.

PMID:
9786103
31.

A randomized trial of nortriptyline for smoking cessation.

Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D.

Arch Intern Med. 1998 Oct 12;158(18):2035-9.

PMID:
9778204
32.

A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain.

Atkinson JH, Slater MA, Williams RA, Zisook S, Patterson TL, Grant I, Wahlgren DR, Abramson I, Garfin SR.

Pain. 1998 Jun;76(3):287-96.

PMID:
9718247
33.

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

Hall SM, Reus VI, Muñoz RF, Sees KL, Humfleet G, Hartz DT, Frederick S, Triffleman E.

Arch Gen Psychiatry. 1998 Aug;55(8):683-90.

PMID:
9707377
34.

Long-term ECG changes in depressed elderly patients treated with nortriptyline. A double-blind, randomized, placebo-controlled evaluation.

Miller MD, Curtiss EI, Marino L, Houck PR, Paradis CF, Mazumdar S, Pollock BG, Foglia J, Reynolds CF 3rd.

Am J Geriatr Psychiatry. 1998 Winter;6(1):59-66.

PMID:
9469215
35.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.

JAMA. 1998 Jan 28;279(4):287-91.

PMID:
9450712
36.

The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline.

Kin NM, Nair NP, Amin M, Schwartz G, Ahmed SK, Holm P, Katona C, Kragh-Sorensen P, Klitgaard N, Song WY, West TE, Stage K.

Biol Psychiatry. 1997 Nov 15;42(10):925-31.

PMID:
9359979
37.

Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.

Reynolds CF 3rd, Buysse DJ, Brunner DP, Begley AE, Dew MA, Hoch CC, Hall M, Houck PR, Mazumdar S, Perel JM, Kupfer DJ.

Biol Psychiatry. 1997 Oct 1;42(7):560-7.

PMID:
9376452
38.

Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial.

Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB.

Psychosom Med. 1997 May-Jun;59(3):241-50.

PMID:
9178335
39.

Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.

Kin NM, Klitgaard N, Nair NP, Amin M, Kragh-Sorensen P, Schwariz G, Ahmed SK, Holm P, Katona C, Stage K.

Neuropsychopharmacology. 1996 Jul;15(1):1-6.

40.

Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients.

Buysse DJ, Reynolds CF 3rd, Hoch CC, Houck PR, Kupfer DJ, Mazumdar S, Frank E.

Neuropsychopharmacology. 1996 Apr;14(4):243-52.

41.

Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.

Gómez-Pérez FJ, Choza R, Ríos JM, Reza A, Huerta E, Aguilar CA, Rull JA.

Arch Med Res. 1996 Winter;27(4):525-9.

PMID:
8987189
42.

A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders.

Powell BJ, Campbell JL, Landon JF, Liskow BI, Thomas HM, Nickel EJ, Dale TM, Penick EC, Samuelson SD, Lacoursiere RB.

Alcohol Clin Exp Res. 1995 Apr;19(2):462-8.

PMID:
7625583
43.

Moclobemide and nortriptyline in elderly depressed patients. A randomized, multicentre trial against placebo.

Nair NP, Amin M, Holm P, Katona C, Klitgaard N, Ng Ying Kin NM, Kragh-Sørensen P, Kühn H, Leek CA, Stage KB.

J Affect Disord. 1995 Jan 11;33(1):1-9.

PMID:
7714303
44.

The cardiovascular effects of bupropion and nortriptyline in depressed outpatients.

Kiev A, Masco HL, Wenger TL, Johnston JA, Batey SR, Holloman LC.

Ann Clin Psychiatry. 1994 Jun;6(2):107-15.

PMID:
7804386
45.

A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms.

Sullivan M, Katon W, Russo J, Dobie R, Sakai C.

Arch Intern Med. 1993 Oct 11;153(19):2251-9.

PMID:
8215728
46.

Nortriptyline in the hospitalized elderly: tolerance and side effect reduction.

Rosen J, Sweet R, Pollock BG, Mulsant BH.

Psychopharmacol Bull. 1993;29(2):327-31.

PMID:
8290682
47.

Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease.

Borson S, McDonald GJ, Gayle T, Deffebach M, Lakshminarayan S, VanTuinen C.

Psychosomatics. 1992 Spring;33(2):190-201.

PMID:
1557484
48.

Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6- to 12-year-olds with major depressive disorder.

Geller B, Cooper TB, Graham DL, Fetner HH, Marsteller FA, Wells JM.

J Am Acad Child Adolesc Psychiatry. 1992 Jan;31(1):34-44.

PMID:
1537779
49.
50.

Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.

Geller B, Cooper TB, Graham DL, Marsteller FA, Bryant DM.

Psychopharmacol Bull. 1990;26(1):85-90.

PMID:
2196631
51.

A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.

Georgotas A, McCue RE, Cooper TB.

Arch Gen Psychiatry. 1989 Sep;46(9):783-6.

PMID:
2673129
52.

Double-blind, placebo-controlled study of nortriptyline in depressed children using a "fixed plasma level" design.

Geller B, Cooper TB, McCombs HG, Graham D, Wells J.

Psychopharmacol Bull. 1989;25(1):101-8. No abstract available.

PMID:
2672066
53.

Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.

Rush AJ, Weissenburger J, Vasavada N, Orsulak PJ, Fairchild CJ.

J Clin Psychopharmacol. 1988 Dec;8(6):421-5.

PMID:
3069882
54.

A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.

Georgotas A, McCue RE, Friedman E, Cooper TB.

J Clin Psychopharmacol. 1987 Dec;7(6):413-6.

PMID:
3323263
55.
56.

Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects.

Nordin C, Bertilsson L, Otani K, Widmark A.

Clin Pharmacol Ther. 1987 Jan;41(1):97-102.

PMID:
3802713
57.
58.

Nortriptyline treatment of post-stroke depression: a double-blind study.

Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR.

Lancet. 1984 Feb 11;1(8372):297-300.

PMID:
6141377
59.

Tranylcypromine vs nortriptyline vs placebo in depressed outpatients: a controlled trial.

White K, Razani J, Cadow B, Gelfand R, Palmer R, Simpson G, Sloane RB.

Psychopharmacology (Berl). 1984;82(3):258-62.

PMID:
6425910
60.

Supplemental Content

Loading ...
Support Center